BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25301730)

  • 1. E-selectin ligand-1 controls circulating prostate cancer cell rolling/adhesion and metastasis.
    Yasmin-Karim S; King MR; Messing EM; Lee YF
    Oncotarget; 2014 Dec; 5(23):12097-110. PubMed ID: 25301730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor cells from prostate cancer patients interact with E-selectin under physiologic blood flow.
    Gakhar G; Navarro VN; Jurish M; Lee GY; Tagawa ST; Akhtar NH; Seandel M; Geng Y; Liu H; Bander NH; Giannakakou P; Christos PJ; King MR; Nanus DM
    PLoS One; 2013; 8(12):e85143. PubMed ID: 24386459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human fucosyltransferase 6 enables prostate cancer metastasis to bone.
    Li J; Guillebon AD; Hsu JW; Barthel SR; Dimitroff CJ; Lee YF; King MR
    Br J Cancer; 2013 Dec; 109(12):3014-22. PubMed ID: 24178760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of prostate cancer cell rolling and adhesion to endothelium by 1α,25-dihydroxyvitamin D3.
    Hsu JW; Yasmin-Karim S; King MR; Wojciechowski JC; Mickelsen D; Blair ML; Ting HJ; Ma WL; Lee YF
    Am J Pathol; 2011 Feb; 178(2):872-80. PubMed ID: 21281819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of glycosyltransferase expression in metastatic prostate cancer cells capable of rolling activity on microvascular endothelial (E)-selectin.
    Barthel SR; Gavino JD; Wiese GK; Jaynes JM; Siddiqui J; Dimitroff CJ
    Glycobiology; 2008 Oct; 18(10):806-17. PubMed ID: 18647941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking.
    Barthel SR; Wiese GK; Cho J; Opperman MJ; Hays DL; Siddiqui J; Pienta KJ; Furie B; Dimitroff CJ
    Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19491-6. PubMed ID: 19889975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells.
    Dimitroff CJ; Descheny L; Trujillo N; Kim R; Nguyen V; Huang W; Pienta KJ; Kutok JL; Rubin MA
    Cancer Res; 2005 Jul; 65(13):5750-60. PubMed ID: 15994950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core 1-derived O-glycans are essential E-selectin ligands on neutrophils.
    Yago T; Fu J; McDaniel JM; Miner JJ; McEver RP; Xia L
    Proc Natl Acad Sci U S A; 2010 May; 107(20):9204-9. PubMed ID: 20439727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordinated and unique functions of the E-selectin ligand ESL-1 during inflammatory and hematopoietic recruitment in mice.
    Sreeramkumar V; Leiva M; Stadtmann A; Pitaval C; Ortega-Rodríguez I; Wild MK; Lee B; Zarbock A; Hidalgo A
    Blood; 2013 Dec; 122(24):3993-4001. PubMed ID: 24106206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin.
    Dimitroff CJ; Lechpammer M; Long-Woodward D; Kutok JL
    Cancer Res; 2004 Aug; 64(15):5261-9. PubMed ID: 15289332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
    Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
    Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of apoptotic signal to rolling cancer cells: a novel biomimetic technique using immobilized TRAIL and E-selectin.
    Rana K; Liesveld JL; King MR
    Biotechnol Bioeng; 2009 Apr; 102(6):1692-702. PubMed ID: 19073014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44.
    Hidalgo A; Peired AJ; Wild M; Vestweber D; Frenette PS
    Immunity; 2007 Apr; 26(4):477-489. PubMed ID: 17442598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity, kinetics, and thermodynamics of E-selectin binding to E-selectin ligand-1.
    Wild MK; Huang MC; Schulze-Horsel U; van der Merwe PA; Vestweber D
    J Biol Chem; 2001 Aug; 276(34):31602-12. PubMed ID: 11404363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow.
    Zarbock A; Ley K; McEver RP; Hidalgo A
    Blood; 2011 Dec; 118(26):6743-51. PubMed ID: 22021370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms by which E-selectin regulates diapedesis of colon cancer cells under flow conditions.
    Tremblay PL; Huot J; Auger FA
    Cancer Res; 2008 Jul; 68(13):5167-76. PubMed ID: 18593916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse bone marrow-derived mast cells roll on P-selectin under conditions of flow in vivo.
    Sriramarao P; Anderson W; Wolitzky BA; Broide DH
    Lab Invest; 1996 Mar; 74(3):634-43. PubMed ID: 8600314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
    Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
    Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The E-selectin-ligand ESL-1 is a variant of a receptor for fibroblast growth factor.
    Steegmaier M; Levinovitz A; Isenmann S; Borges E; Lenter M; Kocher HP; Kleuser B; Vestweber D
    Nature; 1995 Feb; 373(6515):615-20. PubMed ID: 7531823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor cell-specific blockade of CXCR4/SDF-1 interactions in prostate cancer cells by hTERT promoter induced CXCR4 knockdown: A possible metastasis preventing and minimizing approach.
    Xing Y; Liu M; Du Y; Qu F; Li Y; Zhang Q; Xiao Y; Zhao J; Zeng F; Xiao C
    Cancer Biol Ther; 2008 Nov; 7(11):1839-48. PubMed ID: 18836306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.